pixantrone dimaleate

DRUG4 trials

Sponsors

Theradex, CTI BioPharma, Alliance for Clinical Trials in Oncology

Conditions

Breast CancerLeukemiaLymphoma

Phase 1

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

TheradexLymphoma

Start: 2002-02-28Updated: 2009-07-07

Phase 2

Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse

TheradexLymphoma

Start: 2003-04-30Updated: 2009-07-07

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer

CompletedNCT01086605

Alliance for Clinical Trials in OncologyBreast Cancer

Start: 2010-05-31End: 2014-11-15Updated: 2018-05-08

Phase 3

Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

WithdrawnNCT00551239

CTI BioPharmaLeukemia, Lymphoma

Start: 2007-08-31Updated: 2020-10-19

Related Papers

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)

The Oncologist2022-01-132 citations